Design
Review
Authors
Loading...
May improve clinician recognition of cardiorenal syndrome type 1; leaves open need for targeted trials to guide therapy.
Key points are not available for this paper at this time.
Scott F. Gilbert (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: